Is Inovio Pharmaceuticals Stock a Buy?
Investing in clinical-stage biotech companies isn’t for the faint of heart. Negative results from clinical trials or regulatory roadblocks can send shares of these companies plunging. On the other hand, investing in the right clinical-stage biotech stock can reap life-changing returns, particularly if the company in question develops a vaccine for an infectious disease that has spread across the world and has killed thousands of people.
One company that could go on to do just that is Inovio Ph…
